)
)
Adlai Nortye Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Adlai Nortye Ltd
Access all reports
Adlai Nortye Ltd. is a global clinical-stage biopharmaceutical company primarily engaged in developing innovative immuno-oncology medicines. The company's mission is to improve patient lives by discovering and developing differentiated innovative treatments for cancer. It has a strategic focus on oncology, with research and development and global clinical operation centers located in the United States and China. The company is headquartered in North Brunswick, New Jersey, and its shares are listed on the Nasdaq.
Key slides for Adlai Nortye Ltd
Corporate Presentation
Adlai Nortye Ltd
Corporate Presentation
Adlai Nortye Ltd
Latest articles
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
)
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
ANL
Country
🇺🇸 United States